Estrogen-related receptors (ERRs) regulate muscle mitochondria in mice, revealing a new potential drug targets for metabolic ...

POLG-related diseases are a diverse family of conditions all caused by mutations in a gene for a key mitochondrial protein. A newfound molecule could be a promising treatment. | Credit: KATERYNA ...

The number of mitochondrial DNA copies may drop as MS progresses, suggesting a possible biomarker for disease progression, a ...

Children with a mitochondrial disease may miss growth milestones, like speaking or walking by a certain age. To view a list of other symptoms related to PolG, click here. The disease is also ...

Mitochondrial DNA (mtDNA) editing has emerged as a revolutionary approach in the fight against neurodegenerative diseases (NDDs). As these diseases continue to impose a significant global health ...

Mitochondrial diseases affect approximately 1 in 5,000 people worldwide, causing debilitating symptoms ranging from muscle weakness to stroke-like episodes. Some of these conditions result from ...

Mitochondrial diseases affect approximately 1 in 5,000 people worldwide, causing debilitating symptoms ranging from muscle weakness to stroke-like episodes. Some of these conditions result from ...

POLG-related diseases are a diverse family of conditions all caused by mutations in a gene for a key mitochondrial protein. A newfound molecule could be a promising treatment.

POLG disease is a mitochondrial disorder caused by inherited mutations in the POLG gene—which is critical to the processes of replicating cells’ genetic material and DNA repair. The disease ...

"The fundamental processes identified here could establish the basis for new treatment strategies to influence cartilage degeneration and skeletal aging in the context of mitochondrial disorders ...